SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of Marh, 2017

(Commission File No. 1-14862 )

 

 
BRASKEM S.A.
(Exact Name as Specified in its Charter)
 
N/A
(Translation of registrant's name into English)
 


Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)



Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.


 

 

 
 
2017 CALENDAR OF CORPORATE EVENTS

03/28/2017

CALENDAR OF CORPORATE EVENTS

Company Name

Braskem S.A.

Central Office Address

Rua Eteno, 1561, Pólo Petroquímico de Camaçari, Camaçari-BA.

CEP 42810-000

Website

www.braskem.com.br

Chief Financial Officer (CFO)

Name: Pedro van Langendonck Teixeira de Freitas

E-mail: braskem-ri@braskem.com.br

Phone: +55 11 3576-9735 / +55 11 3576-9531

Fax: +55 11 3576-9532

Responsible for Investor Relations Area

Nome: Rosana Cristina Avolio

E-mail: braskem-ri@braskem.com.br

Phone: +55 11 3576-9531

Fax: +55 11 3576-9532

Publications (and locality) in which its corporate documents are published

Diário Oficial do Estado da Bahia (BA)

O Correio da Bahia (BA)

 

Annual Financial Statement and Consolidated Financial Statement, when applicable, as of 12/31/2016

EVENT

DATE

Accessible to Shareholders

To be defined

Submission to BM&FBOVESPA

To be defined

Publication

To be defined

 

Standardized Financial Statement (DFP), as of 12/31/2016

EVENT

DATE

Submission to BM&FBOVESPA

To be defined

 

Annual Financial Statement, in 20F Form, as of 12/31/2016

EVENT

DATE

Submission to BM&FBOVESPA

04.28.2017

 

Reference Form, as of 12/31/2017

EVENT

DATE

Submission to BM&FBOVESPA

05.31.2017

 

Quarterly Financial Statements – ITR

EVENT – Submission to BM&FBOVESPA

DATE

Referring to 1 st quarter of 2017

05.15.2017

Referring to 2 nd quarter of 2017

08.10.2017

Referring to 3 rd quarter of 2017

11.09.2017

 

 

 

 

1

 


 

 

Quarterly Financial Statements – ITR (in English)

EVENT – Submission to BM&FBOVESPA

DATE

Referring to 4 th quarter of 2016

To be defined

Referring to 1 st quarter of 2017

05.16.2017

Referring to 2 nd quarter of 2017

08.11.2017

Referring to 3 rd quarter of 2017

11.10.2017

 

Conference Calls (Optional)

EVENT

DATE

2016 National and International Conference Call

02.22.2017

1 st Quarter of 2017 National and International Conference Call

05.15.2017

2 nd Quarter of 2017 National and International Conference Call

08.11.2017

3 rd Quarter of 2017 National and International Conference Call

11.10.2017

 

Public Meetings with Analysts

EVENT

DATE

Public Meeting with Analysts in São Paulo - SP / 2016 Results

To be defined

08.10.2017

 

Public Meetings with Analysts and Investors

EVENT

DATE

Meeting with Analysts and Investor in New York - NYC / 2016 Results

To be defined

To be defined

 

Annual Shareholders’ Meeting

EVENT

DATE

Publication of the Call Notice

03.29.2017

Submission of the Call Notice to BM&FBOVESPA/CVM

03.29.2017

Submission of the Management Proposal to BM&FBOVESPA/CVM

03.29.2017

Annual Shareholders’ Meeting

04.28.2017

Submission of the Minutes of the Annual Shareholders’ Meeting to BM&FBOVESPA

04.28.2017

 

 

Board of Directors’ Meetings (already scheduled)

EVENT

DATE

Referring to Fiscal Year 2016

To be defined

Submission to BM&FBOVESPA

To be defined

 

 

Referring to 1 st quarter of 2017

05.12.2017

Submission to BM&FBOVESPA

05.12.2017

 

 

Referring to 2 nd quarter of 2017

08.09.2017

Submission to BM&FBOVESPA

08.09.2017

 

 

Referring to 3 rd quarter of 2017

11.08.2017

Submission to BM&FBOVESPA

11.08.2017

 

2

 

 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 28, 2017
  BRASKEM S.A.
 
 
  By:      /s/     Pedro van Langendonck Teixeira de Freitas
 
    Name: Pedro van Langendonck Teixeira de Freitas
    Title: Chief Financial Officer

 

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates offuture economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.